Skip to main content
. 2022 Mar 29;29(2):143–156. doi: 10.3390/pathophysiology29020013

Table 1.

Characteristics of the study population.

COPD Smoker Non-Smoker
Group 1 (n = 15) 2 (n = 15) 3 (n = 15)
Age (years) 67.07 ± 12.24 55.66 ± 12.41 62.46 ± 12.38
Gender (M/F; n) (%) 8 (53.33)/7 (46.66) 10 (66.67)/5 (33.33) † 3 (20)/12 (80)
BMI (kg/m2) 26.12 ± 4.07 26.10 ± 3.10 24.58 ± 4.57
Pack-years 51.61 ± 42.16 † 36.66 ± 27.38† 0 ± 0
Smoking status
Current smoker 7 (46.60%) 4 (26.60 %) 0 (0%)
Former smoker 8 (53.30%) 11 (73.30%) 0 (0%)
Non-smoker 0 (0%) 0 (0%) 15 (100%)
FEV1/FVC (%) 57.26 ± 8.78 *† 76.90 ± 4.63 76.83 ± 6.36
FEV1 (% Ref) 61.23 ± 18.17 *† 94.81 ± 17.10 97.00 ± 10.86
COPD Stage (%)
GOLD 1 2 (13.30%)
GOLD 2 10 (66.67%)
GOLD 3 3 (20%)
GOLD 4 0 (0%)

Data represents mean and SD. COPD, chronic obstructive pulmonary disease. COPD stage used GOLD standard [3]. * p < 0.05 compared to Smoker. † p < 0.05 compared to non-smoker.